MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
|
Citation:
|
MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
|
MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
|
Citation:
|
MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
|
DownLoad: